Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands

Brechje de Gier, Stijn Andeweg, Jantien A. Backer, RIVM COVID-19 surveillance and epidemiology team, Susan J.M. Hahné, Susan van den Hof, Hester E. de Melker, Mirjam J. Knol
doi: https://doi.org/10.1101/2021.10.14.21264959

Article Information

doi 
https://doi.org/10.1101/2021.10.14.21264959
History 
  • October 14, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Brechje de Gier1,*,
  2. Stijn Andeweg1,
  3. Jantien A. Backer1,
  4. RIVM COVID-19 surveillance and epidemiology team,
  5. Susan J.M. Hahné1,
  6. Susan van den Hof1,
  7. Hester E. de Melker1 and
  8. Mirjam J. Knol1
  1. 1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
  1. ↵* Corresponding author; email: brechje.de.gier{at}rivm.nl
Back to top
Posted October 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands
Brechje de Gier, Stijn Andeweg, Jantien A. Backer, RIVM COVID-19 surveillance and epidemiology team, Susan J.M. Hahné, Susan van den Hof, Hester E. de Melker, Mirjam J. Knol
medRxiv 2021.10.14.21264959; doi: https://doi.org/10.1101/2021.10.14.21264959
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area